Nationwide Newborn Screening Program for Mucopolysaccharidoses in Taiwan and an Update of the “Gold Standard” Criteria Required to Make a Confirmatory Diagnosis
Mucopolysaccharidoses (MPSs) are a group of lysosomal storage diseases (LSDs) caused by an inherited gene defect. MPS patients can remain undetected unless the initial signs or symptoms have been identified. Newborn screening (NBS) programs for MPSs have been implemented in Taiwan since 2015, and mo...
Main Authors: | Chih-Kuang Chuang, Chung-Lin Lee, Ru-Yi Tu, Yun-Ting Lo, Fran Sisca, Ya-Hui Chang, Mei-Ying Liu, Hsin-Yun Liu, Hsiao-Jan Chen, Shu-Min Kao, Li-Yun Wang, Huey-Jane Ho, Hsiang-Yu Lin, Shuan-Pei Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/11/9/1583 |
Similar Items
-
Mucopolysaccharidoses: early diagnostic signs in infants and children
by: Cinzia Galimberti, et al.
Published: (2018-11-01) -
Molecular basis, diagnosis and clinical management of mucopolysaccharidoses
by: Rossella Parini, et al.
Published: (2013-02-01) -
Critical clinical situations in adult patients with Mucopolysaccharidoses (MPS)
by: Karolina M. Stepien, et al.
Published: (2020-05-01) -
Ocular features in mucopolysaccharidosis: diagnosis and treatment
by: Alessandra Del Longo, et al.
Published: (2018-11-01) -
Intravenous Enzyme Replacement Therapy in Mucopolysaccharidoses: Clinical Effectiveness and Limitations
by: Rossella Parini, et al.
Published: (2020-04-01)